A new algorithm for the evaluation of recurrent pregnancy loss redefining unexplained miscarriage: review of current guidelines
Open Access
- 3 July 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 32 (5) , 371-379
Abstract
Purpose of review: Couples with recurrent pregnancy loss (RPL) are often referred to reproductive specialists to help determine the reason for their repeated losses. This review will help to develop a strategy that is effective in providing a diagnosis, efficient to administer, and cost-effective to the healthcare system. Recent findings: International societies have published different recommendations for the evaluation of RPL, they consider it appropriate to initiate an evaluation after two (or three) clinical miscarriages. On the contrary, the clinician who follows these guidelines will only be able to offer a possible explanation to fewer than half of the couples being evaluated. Recently, genetic testing of miscarriage tissue using 24-chromosome microarray (CMA) analysis at the time of the second pregnancy loss coupled with testing based on society guidelines has been shown provide an explanation in more than 90% of cases. Summary: New guidelines for the complete evaluation of RPL should consider adding 24-CMA testing on the miscarriage tissue. Providing couples with an explanation for recurrent loss assists them in dealing with the loss and discourages the clinician from instituting unproven therapies. Truly unexplained pregnancy loss can be reduced to less than 10% with this new algorithm. Incorporation of these strategies will result in significant cost savings to the healthcare system.Keywords
This publication has 36 references indexed in Scilit:
- Genetics of early miscarriageBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Practice Bulletin No. 132Obstetrics & Gynecology, 2012
- Evaluation and treatment of recurrent pregnancy loss: a committee opinionFertility and Sterility, 2012
- Is chromosome testing of the second miscarriage cost saving? A decision analysis of selective versus universal recurrent pregnancy loss evaluationFertility and Sterility, 2012
- VTE, Thrombophilia, Antithrombotic Therapy, and PregnancyChest, 2012
- ‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010Lupus, 2011
- Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy lossesFertility and Sterility, 2010
- Diagnosis of miscarriages by molecular karyotyping: Benefits and pitfallsGenetics in Medicine, 2009
- Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin aloneAmerican Journal of Obstetrics and Gynecology, 1996
- Incidence of Early Loss of PregnancyNew England Journal of Medicine, 1988